Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study-Reference-Cited by-同舟云学术

Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study

Published:2013-07-23 Issue:12 Volume:21 Page:3271-3278
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Nagai Hiroki,Kitano Toshiyuki,Nishimura Takafumi,Yasuda Hiroyasu,Nakata Kazumi,Takashima Sachie,Kanai Masashi,Matsumoto Shigemi,Mori Yukiko,Kakudo Yuichi,Sato Hiroyasu,Yamaguchi Takuhiro,Kameno Kaoru,Kim Young Hak,Mishima Michiaki,Yanagihara Kazuhiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-013-1901-9.pdf

Reference19 articles.

1. Pittman KB, Olver IN, Koczwara B, Kotasek D, Patterson WK, Keefe DM, Karapetis CS, Parnis FX, Moldovan S, Yeend SJ, Price TJ, Adelaide Cancer Trials and Education Collaborative (ACTEC) (2006) Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. Br J Cancer 95:1309–1313

2. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

3. Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, Mattson K, Manegold C, Palmer MC, Gregor A, Nquyen B, Niyikiza C, Einhorn LH (2000) Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18:122–130

4. Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N, Mauceri G, Caruso M, Tirrito ML, Valdesi M (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19:4089–4091

5. von der Maase H, Hansen SW, Roberts JT, Doqliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068–3077

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain;Anticancer Research;2021-12-29

2. Risk Factors for Gemcitabine-Induced Vascular Pain in Patients With Pancreatic Cancer;Annals of Pharmacotherapy;2020-10-23

3. Outcomes of Clinical Pharmacy Research Aimed at Avoiding or Reducing Cancer Chemotherapy-induced Adverse Reaction;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-09-10

4. Liquid Formulation of Gemcitabine Increases Venous Pain in Patients With Cancer: A Retrospective Study;Clinical Therapeutics;2020-04

5. Continuous thermographic observation may predict extravasation in chemotherapy-treated patients;European Journal of Oncology Nursing;2017-06